BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 7853418)

  • 1. Expression of scatter factor in human bladder carcinoma.
    Joseph A; Weiss GH; Jin L; Fuchs A; Chowdhury S; O'Shaugnessy P; Goldberg ID; Rosen EM
    J Natl Cancer Inst; 1995 Mar; 87(5):372-7. PubMed ID: 7853418
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Urinary and tissue levels of scatter factor in transitional cell carcinoma of bladder.
    Rosen EM; Joseph A; Jin L; Yao Y; Chau MH; Fuchs A; Gomella L; Hastings H; Goldberg ID; Weiss GH
    J Urol; 1997 Jan; 157(1):72-8. PubMed ID: 8976219
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Scatter factor/hepatocyte growth factor gene transfer enhances glioma growth and angiogenesis in vivo.
    Laterra J; Nam M; Rosen E; Rao JS; Lamszus K; Goldberg ID; Johnston P
    Lab Invest; 1997 Apr; 76(4):565-77. PubMed ID: 9111517
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of scatter factor and c-met receptor in benign and malignant breast tissue.
    Jin L; Fuchs A; Schnitt SJ; Yao Y; Joseph A; Lamszus K; Park M; Goldberg ID; Rosen EM
    Cancer; 1997 Feb; 79(4):749-60. PubMed ID: 9024713
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Scatter factor stimulates tumor growth and tumor angiogenesis in human breast cancers in the mammary fat pads of nude mice.
    Lamszus K; Jin L; Fuchs A; Shi E; Chowdhury S; Yao Y; Polverini PJ; Laterra J; Goldberg ID; Rosen EM
    Lab Invest; 1997 Mar; 76(3):339-53. PubMed ID: 9121117
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Overexpression of c-met as a prognostic indicator for transitional cell carcinoma of the urinary bladder: a comparison with p53 nuclear accumulation.
    Cheng HL; Trink B; Tzai TS; Liu HS; Chan SH; Ho CL; Sidransky D; Chow NH
    J Clin Oncol; 2002 Mar; 20(6):1544-50. PubMed ID: 11896103
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatocyte growth factor and its receptor (c-MET) in prostatic carcinoma.
    Humphrey PA; Zhu X; Zarnegar R; Swanson PE; Ratliff TL; Vollmer RT; Day ML
    Am J Pathol; 1995 Aug; 147(2):386-96. PubMed ID: 7639332
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Overexpression and regulation of expression of scatter factor/hepatocyte growth factor in prostatic carcinoma.
    Zhu X; Humphrey PA
    Urology; 2000 Dec; 56(6):1071-4. PubMed ID: 11113771
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Scatter factor/hepatocyte growth factor (SF/HGF) content and function in human gliomas.
    Lamszus K; Laterra J; Westphal M; Rosen EM
    Int J Dev Neurosci; 1999; 17(5-6):517-30. PubMed ID: 10571413
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Scatter factor promotes motility of human glioma and neuromicrovascular endothelial cells.
    Lamszus K; Schmidt NO; Jin L; Laterra J; Zagzag D; Way D; Witte M; Weinand M; Goldberg ID; Westphal M; Rosen EM
    Int J Cancer; 1998 Jan; 75(1):19-28. PubMed ID: 9426685
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Heat-shock protein 70-2 (HSP70-2) expression in bladder urothelial carcinoma is associated with tumour progression and promotes migration and invasion.
    Garg M; Kanojia D; Seth A; Kumar R; Gupta A; Surolia A; Suri A
    Eur J Cancer; 2010 Jan; 46(1):207-15. PubMed ID: 19914824
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation of angiogenesis by scatter factor.
    Rosen EM; Goldberg ID
    EXS; 1997; 79():193-208. PubMed ID: 9002233
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High expression of polo-like kinase 1 is associated with the metastasis and recurrence in urothelial carcinoma of bladder.
    Zhang Z; Zhang G; Kong C
    Urol Oncol; 2013 Oct; 31(7):1222-30. PubMed ID: 22192978
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fibroblast growth factor receptor 3 is overexpressed in urinary tract carcinomas and modulates the neoplastic cell growth.
    Gómez-Román JJ; Saenz P; Molina M; Cuevas González J; Escuredo K; Santa Cruz S; Junquera C; Simón L; Martínez A; Gutiérrez Baños JL; López-Brea M; Esparza C; Val-Bernal JF
    Clin Cancer Res; 2005 Jan; 11(2 Pt 1):459-65. PubMed ID: 15701828
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overexpression of scatter factor and its receptor (c-met) in oral squamous cell carcinoma.
    Marshall DD; Kornberg LJ
    Laryngoscope; 1998 Sep; 108(9):1413-7. PubMed ID: 9738769
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Scatter factor expression and regulation in human glial tumors.
    Rosen EM; Laterra J; Joseph A; Jin L; Fuchs A; Way D; Witte M; Weinand M; Goldberg ID
    Int J Cancer; 1996 Jul; 67(2):248-55. PubMed ID: 8760595
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential expression of hepatocyte growth factor in papillary and nodular tumors of the bladder.
    Li B; Kanamaru H; Noriki S; Fukuda M; Okada K
    Int J Urol; 1998 Sep; 5(5):436-40. PubMed ID: 9781430
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Scatter factor and angiogenesis.
    Rosen EM; Goldberg ID
    Adv Cancer Res; 1995; 67():257-79. PubMed ID: 8571817
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulation of uveal melanoma interconverted phenotype by hepatocyte growth factor/scatter factor (HGF/SF).
    Hendrix MJ; Seftor EA; Seftor RE; Kirschmann DA; Gardner LM; Boldt HC; Meyer M; Pe'er J; Folberg R
    Am J Pathol; 1998 Apr; 152(4):855-63. PubMed ID: 9546344
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical implications of the expression of epidermal growth factor receptors in human transitional cell carcinoma.
    Messing EM
    Cancer Res; 1990 Apr; 50(8):2530-7. PubMed ID: 1690599
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.